Rahul Sharma, MD
Interventional Cardiology · Stanford, CANPI 1548735509
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (58.5%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 27 manufacturers reported payments, led by Edwards Lifesciences at 49.9% of the total. Reporting peaked in 2023 at $324,972 and has fallen 57.4% since, to $138,515 in 2025. Among interventional cardiology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,800 payments — averaging $573.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$516K
- Cathworks, Inc.$257K
- Abbott$103K
- Siemens Medical Solutions USA, Inc.$44K
- Shockwave Medical, Inc$40K
- Medtronic$20K
- plus $53K from 21 others
Across 251 payments — averaging $22,138 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Edwards Lifesciences$4.8M
- Boston Scientific$537K
- Abbott$177K
- Biosense Webster, Inc.$21K
- Medtronic$5K
What the payments were for
- Consulting fees$604,57459%
- Speaking & faculty fees$164,48316%
- Travel & lodging$187,31218%
- Food & beverage$76,5697%
- Education$10%
- Entertainment$1500%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 1,158 | $515,851 |
| Cathworks, Inc. | 51 | $257,239 |
| Abbott | 196 | $102,826 |
| Siemens Medical Solutions USA, Inc. | 21 | $44,456 |
| Shockwave Medical, Inc | 74 | $40,174 |
| Medtronic(2 entities) | 90 | $19,935 |
| Philips North America LLC | 55 | $18,092 |
| Cardiva Medical, Inc. | 13 | $14,769 |
| Boston Scientific | 107 | $8,954 |
| Opsens Inc. | 7 | $8,041 |
| Cvrx, Inc. | 9 | $1,270 |
| Merz North America, Inc. | 1 | $261 |
| Biotronik Inc. | 2 | $191 |
| Viz.ai, Inc. | 1 | $183 |
| Penumbra, Inc. | 1 | $156 |
| Terumo Medical Corporation | 1 | $142 |
| W. L. Gore & Associates, Inc. | 3 | $136 |
| Abiomed | 1 | $92 |
| Biosense Webster, Inc. | 1 | $77 |
| Atricure, Inc. | 1 | $52 |
| Teleflex LLC | 1 | $42 |
| Asahi Intecc USA, Inc. | 1 | $36 |
| Cardiac Dimensions, Inc. | 1 | $32 |
| Jenavalve Technology, Inc. | 1 | $26 |
| Angiodynamics, Inc. | 1 | $22 |
| AstraZeneca | 1 | $19 |
| Lupin Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Edwards SAPIEN 3 Transcatheter Heart Valve$250,674
- FFRangio$230,832
- PASCAL$57,768
- AMPLATZER AMULET$43,903
- ACUSON SC2000 Diagnostic Ultrasound System$43,645
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$39,136
- FFRangio System$30,829
- SavvyWire$22,323
- JETi All In One Non-Sterile Kit$19,950
- Mitra Clip system$16,714
- EVOQUE$15,712
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$14,795
- (9520) IGT Devices Undivided$9,380
- SAPIEN 3 Ultra RESILIA$5,186
- (9148) ICE 3D$4,651
- MitraClip$3,329
- Perclose ProGlide suture mediated closure system$2,666
- Omnilink Elite vascular stent system$2,500
- MitraClip System$2,216
- WATCHMAN Access System$2,017
How this compares
$1,033,088 in reported general payments places this provider in the 95th percentile of 585 interventional cardiology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 22 | $392 |
| Prednisone | 17 | $56 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Stanford
- Jennifer TremmelStanford$233K
- David LeeStanford$231K
- Todd BrintonStanford$150K
- Matthew Pricela Jolla$2.3M
- Frederick St GoarMountain View$2.2M
- Saibal KarThousand Oaks$1.1M
- Puneet KhannaRancho Mirage$1M
- Dennis SheehanRedwood City$900K
- Suhail DohadBeverly Hills$802K
- Curtiss Stinisla Jolla$759K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.